Avoro Capital Advisors
$9.8B Assets Reported
37 Holdings
Latest filing 2026-03-31
Top Holdings
| Ticker | Company | Shares | Value | Weight |
|---|---|---|---|---|
| UTHR | UNITED THERAPEUTICS CORP | 3,010,000 | $1.6B | 16.1% |
| ASND | ASCENDIS PHARMA | 5,062,500 | $1.2B | 11.8% |
| MDGL | MADRIGAL PHARMACEUTICALS INC | 1,818,181 | $952M | 9.7% |
| KRYS | KRYSTAL BIOTECH INC | 2,888,888 | $746M | 7.6% |
| ARGX | ARGENX SE | 1,000,000 | $730M | 7.5% |
| ARWR | ARROWHEAD PHARMACEUTICALS INC | 10,699,999 | $671M | 6.9% |
| KYMR | KYMERA THERAPEUTICS INC | 7,474,747 | $623M | 6.4% |
| APLS | APELLIS PHARMACEUTICALS INC | 12,222,222 | $492M | 5.0% |
| CNTA | CENTESSA PHARMACEUTICALS PLC | 11,430,455 | $454M | 4.6% |
| XENE | XENON PHARMACEUTICALS INC | 5,777,777 | $336M | 3.4% |
Track Avoro Capital Advisors's 13F portfolio: $9.8B in reported holdings, 37 positions. Top holdings, AUM, and quarterly changes on SentiSense.